These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18360844)

  • 1. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis.
    Buellesfeld L; Gerckens U; Grube E
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):579-84. PubMed ID: 18360844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis.
    Grube E; Laborde JC; Zickmann B; Gerckens U; Felderhoff T; Sauren B; Bootsveld A; Buellesfeld L; Iversen S
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):465-9. PubMed ID: 16208696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.
    Treede H; Tübler T; Reichenspurner H; Grube E; Pascotto A; Franzen O; Mueller R; Low R; Bolling SF; Meinertz T; Schofer J
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):897-903. PubMed ID: 20392455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new generation is coming. Percutaneous implantation of the fully repositionable Lotus® aortic valve prosthesis: the first Polish experience.
    Grygier M; Araszkiewicz A; Lesiak M; Oko-Sarnowska Z; Trojnarska O; Olasińska-Wiśniewska A; Misterski M; Buczkowski P; Jemielity M; Grajek S
    Kardiol Pol; 2015; 73(2):80-4. PubMed ID: 25299402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
    Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I have seen the future, and it works-Lincoln Steffens (1866-1936).
    Block PC
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):585-6. PubMed ID: 18360845
    [No Abstract]   [Full Text] [Related]  

  • 7. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System.
    Kocher AA; Laufer G; Haverich A; Shrestha M; Walther T; Misfeld M; Kempfert J; Gillam L; Schmitz C; Wahlers TC; Wippermann J; Mohr FW; Roth M; Skwara A; Rahmanian P; Wiedemann D; Borger MA
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):110-5; discussion 115-6. PubMed ID: 23058665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system.
    Fraccaro C; Napodano M; Tarantini G; Gasparetto V; Gerosa G; Bianco R; Bonato R; Pittarello D; Isabella G; Iliceto S; Ramondo A
    JACC Cardiovasc Interv; 2009 Sep; 2(9):828-33. PubMed ID: 19778770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated aortic bioprosthesis.
    Bruschi G; DeMarco F; Oreglia J; Colombo P; Fratto P; Lullo F; Paino R; Martinelli L; Klugmann S
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):182-5. PubMed ID: 19829135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transapical approach for aortic valve implantation.
    Zierer A; Wimmer-Greinecker G; Martens S; Moritz A; Doss M
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):948-53. PubMed ID: 18954635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic valve replacement with new-generation stentless pericardial valves: short-term clinical and hemodynamic results.
    Grubitzsch H; Linneweber J; Kossagk C; Sanli E; Beholz S; Konertz WF
    J Heart Valve Dis; 2005 Sep; 14(5):623-9. PubMed ID: 16245501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Nerla R; Cremonesi A; Castriota F
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):169-174. PubMed ID: 27143596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients.
    Ye J; Cheung A; Lichtenstein SV; Pasupati S; Carere RG; Thompson CR; Sinhal A; Webb JG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):16-21. PubMed ID: 17126558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of a degenerative stenosed CoreValve(®) aortic bioprosthesis by transcatheter valve-in-valve insertion.
    Hammerstingl C; Nickenig G; Grube E
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):748-55. PubMed ID: 21735534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study.
    Meredith IT; Worthley SG; Whitbourn RJ; Antonis P; Montarello JK; Newcomb AE; Lockwood S; Haratani N; Allocco DJ; Dawkins KD
    EuroIntervention; 2014 Mar; 9(11):1264-70. PubMed ID: 24169077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.
    Grube E; Laborde JC; Gerckens U; Felderhoff T; Sauren B; Buellesfeld L; Mueller R; Menichelli M; Schmidt T; Zickmann B; Iversen S; Stone GW
    Circulation; 2006 Oct; 114(15):1616-24. PubMed ID: 17015786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transaortic transcatheter aortic valve implantation within a previous bioprosthetic aortic valve replacement.
    Cockburn J; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):479-84. PubMed ID: 21793174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis.
    Tamburino C; Capodanno D; Mulè M; Scarabelli M; Cammalleri V; Barbanti M; Calafiore A; Ussia G
    J Invasive Cardiol; 2009 Mar; 21(3):93-8. PubMed ID: 19258637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system.
    Binder RK; Schäfer U; Kuck KH; Wood DA; Moss R; Leipsic J; Toggweiler S; Freeman M; Ostry AJ; Frerker C; Willson AB; Webb JG
    JACC Cardiovasc Interv; 2013 Mar; 6(3):301-7. PubMed ID: 23517843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system.
    Grube E; Buellesfeld L; Mueller R; Sauren B; Zickmann B; Nair D; Beucher H; Felderhoff T; Iversen S; Gerckens U
    Circ Cardiovasc Interv; 2008 Dec; 1(3):167-75. PubMed ID: 20031675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.